Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127572581 | 12757258 | 1 | I | 20151110 | 20160919 | 20160919 | PER | US-ALVOGEN-2015-ALVOGEN-020340 | ALVOGEN | 54.00 | YR | F | Y | 0.00000 | 20160919 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127572581 | 12757258 | 1 | PS | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | U | 62800 | INJECTION | ||||||||||
127572581 | 12757258 | 2 | SS | VANCOMYCIN | VANCOMYCIN | 1 | U | 0 | INJECTION | ||||||||||
127572581 | 12757258 | 3 | SS | ALTACE | RAMIPRIL | 1 | U | 0 | CAPSULE | ||||||||||
127572581 | 12757258 | 4 | SS | AMOXICILLIN. | AMOXICILLIN | 1 | U | 0 | |||||||||||
127572581 | 12757258 | 5 | SS | ERYTHROMYCIN. | ERYTHROMYCIN | 1 | U | 0 | |||||||||||
127572581 | 12757258 | 6 | SS | LOTENSIN | BENAZEPRIL HYDROCHLORIDE | 1 | U | 0 | |||||||||||
127572581 | 12757258 | 7 | SS | VALIUM | DIAZEPAM | 1 | U | 0 | |||||||||||
127572581 | 12757258 | 8 | C | PETHIDINE HYDROCHLORIDE | MEPERIDINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
127572581 | 12757258 | 9 | C | TRAMADOL HYDROCHLORIDE. | TRAMADOL HYDROCHLORIDE | 1 | SUSTAINED RELEASE TABLETS | 0 | TABLET | ||||||||||
127572581 | 12757258 | 10 | C | CODEINE | CODEINE | 1 | 0 | ||||||||||||
127572581 | 12757258 | 11 | C | INOSINE | INOSINE | 1 | 0 | ||||||||||||
127572581 | 12757258 | 12 | C | TETANUS TOXOID ADSORBED | CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) | 1 | 0 | ||||||||||||
127572581 | 12757258 | 13 | C | CARVEDILOL. | CARVEDILOL | 1 | 0 | 20 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127572581 | 12757258 | 1 | Product used for unknown indication |
127572581 | 12757258 | 2 | Product used for unknown indication |
127572581 | 12757258 | 3 | Product used for unknown indication |
127572581 | 12757258 | 4 | Product used for unknown indication |
127572581 | 12757258 | 5 | Product used for unknown indication |
127572581 | 12757258 | 6 | Product used for unknown indication |
127572581 | 12757258 | 7 | Product used for unknown indication |
127572581 | 12757258 | 8 | Product used for unknown indication |
127572581 | 12757258 | 9 | Product used for unknown indication |
127572581 | 12757258 | 10 | Product used for unknown indication |
127572581 | 12757258 | 11 | Product used for unknown indication |
127572581 | 12757258 | 12 | Product used for unknown indication |
127572581 | 12757258 | 13 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127572581 | 12757258 | Drug hypersensitivity |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |